Mylotarg and blood urea increased 
Mylotarg and blood urea increased Patient Reports February 12, 2012
Mylotarg Side Effects Report #5158527-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 07, 2006. Female patient, 73 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, condition aggravated, disease progression, disseminated intravascular coagulation, febrile neutropenia, hyperuricaemia, hypokalaemia, white blood cell count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY. During the same period patient was treated with LIVALO, ENALAPRIL MALEATE, ADALAT OR, METHYCOBAL, ASPARA K, MUCOSOLVAN, LEVOFLOXACIN. Patient recovered.
Mylotarg Side Effects Report #5081982-4
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on July 31, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood potassium decreased, blood urea increased, performance status decreased, petechiae, platelet count decreased, sepsis
, venoocclusive liver disease, white blood cell count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE, INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA, FEPRAZONE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5119945-2
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Sept 22, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood calcium decreased, blood creatinine increased, blood lactate dehydrogenase increased, blood potassium decreased, blood urea increased, gamma-glutamyltransferase increased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA, FEPRAZONE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4943875-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Feb 28, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood calcium decreased, blood creatinine increased, blood potassium decreased, blood urea increased, haemorrhagic diathesis, malignant neoplasm progression, neutrophil percentage decreased, platelet count decreased. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA. Patient died.
Mylotarg Side Effects Report #5026232-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 31, 2006. Male patient, 66 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood calcium decreased, blood creatinine increased, blood potassium decreased, blood urea increased, haemorrhagic diathesis, neutrophil percentage decreased, performance status decreased, platelet count decreased, portal hypertension. Mylotarg dosage: A SINGLE 9 MG/M^2 DOSE INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with CYTARABINE, DAUNORUBICIN, DIFLUCAN, CLARITHROMYCIN, FAMOTIDINE, MUCOSTA. Patient died.
Mylotarg Side Effects Report #5121147-0
Mylotarg side effect was reported by a Health Professional from JAPAN on Sept 22, 2006. Male patient, 64 years of age, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, blood urea increased, bone marrow failure, cancer pain, cardiac failure congestive, chills, constipation
, disseminated intravascular coagulation. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with NEUQUINON, METHYCOBAL, SUCRALFATE, LANSOPRAZOLE. Patient was hospitalized. Patient died.Mylotarg Side Effects Report #5259682-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 02, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, performance status decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FUNGUARD, MEROPEN, ISEPACIN. Patient recovered.
Mylotarg Side Effects Report #5315496-0
Mylotarg side effect was reported by a Physician from JAPAN on Apr 24, 2007. Male patient, weighting 154.3 lb, was diagnosed with acute myeloid leukaemia recurrent and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, anaemia, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, chills. Mylotarg dosage: unknown. During the same period patient was treated with HYDROCORTISONE SUCCINATE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #5318951-2
Mylotarg side effect was reported by a Physician from JAPAN on Apr 27, 2007. Male patient, weighting 143.3 lb, was diagnosed with acute myeloid leukaemia recurrent, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, body temperature increased, c-reactive protein increased, hypoalbuminaemia, hypoproteinaemia, performance status decreased. Mylotarg dosage: unknown. During the same period patient was treated with MAXIPIME, FUNGUARD, MEROPEN, ISEPACIN. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #6130073-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 19, 2009. Male patient, weighting 119.0 lb, was diagnosed with acute myeloid leukaemia recurrent, anxiety
, insomnia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, hypoalbuminaemia, neutropenia, pneumonia , thrombocytopenia. Mylotarg dosage: unknown. During the same period patient was treated with DEPAS, SILECE, ACLACINON, CRAVIT. Patient was hospitalized. Patient died on 08/10/2007.Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis
, deep vein thrombosis , disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.Mylotarg Side Effects Report #4802758-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Oct 03, 2005. Female patient, 85 years of age, weighting 141.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cellulitis
, deep vein thrombosis , disease progression, haemoglobin decreased, white blood cell count decreased. Mylotarg dosage: 15.5 MG OVER 2 HOURS, INTRAVENOUS. During the same period patient was treated with VANCOMYCIN, LEVAQUIN, DIFLUCAN, VALTREX, AMBIEN, TAMOXIFEN CITRATE, SENOKOT. Patient was hospitalized. Patient died on 04/27/2004.Mylotarg Side Effects Report #4955671-8
Mylotarg side effect was reported by a Health Professional from JAPAN on Mar 10, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, febrile neutropenia, liver disorder, malignant neoplasm progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with ACLARUBICIN HYDROCHLORIDE, FOSMICIN S, MAXIPIME, VANCOMYCIN, FUNGUARD, PAZUCROSS. Patient recovered.
Mylotarg Side Effects Report #5007450-3
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on May 09, 2006. Female patient, 85 years of age, was diagnosed with acute myeloid leukaemia, sepsis
and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, disease progression. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CARBENIN, CIPROFLOXACIN, FOSMICIN S, FOSMICIN S, FUNGUARD, MAXIPIME. Patient recovered.Mylotarg Side Effects Report #5093595-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 17, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood calcium decreased, blood potassium decreased, blood urea increased, disease progression, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE, INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.
Mylotarg Side Effects Report #4951697-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Male patient, 78 years of age, weighting 139.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal discomfort, acute myeloid leukaemia, ascites, blood potassium decreased, blood urea increased, blood uric acid increased, decreased appetite, febrile neutropenia, haematemesis. Mylotarg dosage: 15 MG ONE TIME PER ONE DOSE INTRAVENOUS. During the same period patient was treated with ACETAMINOPHEN, DOCUSATE, DIPHENHYDRAMINE, HYDROXYUREA, ALLOPURINOL, TRAZODONE, PERCOCET, SEREVENT. Patient was hospitalized. Patient died on 04/26/2002.
Mylotarg Side Effects Report #4851409-3
Mylotarg side effect was reported by a Health Professional from JAPAN on Nov 29, 2005. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood creatinine increased, blood urea increased, cardiac failure, disease progression, hyperhidrosis, hypotension, infusion related reaction, pneumonia
. Mylotarg dosage: 7 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. Patient died.Mylotarg Side Effects Report #4949644-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 77 years of age, weighting 147.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardiomegaly, chills, cough, dyspnoea, fall
, febrile neutropenia, haematocrit decreased. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4970755-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Mar 29, 2006. Male patient, 77 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: arteriosclerosis, blood creatinine increased, blood urea increased, c-reactive protein increased, cardiac failure, disease progression, electrocardiogram abnormal, hyperhidrosis, hypotension. Mylotarg dosage: 7 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ALLOPURINOL, DEXAMETHASONE PHOSPHATE, CHLORPHENIRAMINE MALEATE. Patient died.
Mylotarg Side Effects Report #5147197-6
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 02, 2006. Female patient, 76 years of age, was diagnosed with acute myeloid leukaemia, pneumonia
, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, haematocrit decreased, haemoglobin decreased, hypernatraemia, liver disorder, neutrophil count decreased, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with CIPROXAN, NEUPOGEN, OMEGACIN, VANCOMYCIN, STRONG NEO MINOPHAGEN C, VFEND. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4944147-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, blood urea increased, body temperature decreased, bronchoalveolar lavage abnormal, cryptogenic organizing pneumonia, dyspnoea, fungal infection
, granuloma, haematocrit decreased. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KEKTOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5023688-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on May 23, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blast cell count increased, blood bicarbonate decreased, blood urea increased, cryptogenic organizing pneumonia, diffuse alveolar damage, fungal infection
, haematocrit decreased, haemoglobin decreased, hypotension. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KETOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5037506-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 09, 2006. Male patient, 76 years of age, weighting 167.6 lb, was diagnosed with acute myeloid leukaemia, myelodysplastic syndrome and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bicarbonate decreased, blood urea increased, body temperature decreased, carbon dioxide decreased, computerised tomogram abnormal, diffuse alveolar damage, dyspnoea, fungal infection
, granuloma. Mylotarg dosage: 6 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with TRISENOX, KETOCONAZOLE, ACYCLOVIR, ATENOLOL, SYNTHROID, VITAMINS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #5041922-0
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 21, 2006. Male patient, 76 years of age, weighting 189.6 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, abdominal pain
, ascites, aspartate aminotransferase increased, blood albumin decreased, blood creatinine increased, blood urea increased, haemoglobin decreased, platelet count decreased. Mylotarg dosage: 18 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with FLAGYL, ACETAMINOPHEN, ZOVIRAX, NORVASC, ROCEPHIN, LOPRESSOR, PROTONIX, VORICONAZOLE. Patient recovered.Mylotarg Side Effects Report #5129071-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 29, 2006. Male patient, 74 years of age, weighting 137.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood culture positive, blood urea increased, febrile neutropenia, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4759110-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 18, 2005. Male patient, 74 years of age, weighting 137.8 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood culture positive, blood glucose increased, blood magnesium abnormal, blood urea increased, febrile neutropenia, platelet count abnormal. Mylotarg dosage: unknown. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4998575-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Apr 24, 2006. Male patient, 74 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, ascites, blood urea increased, body temperature increased, disease progression, fatigue, febrile neutropenia, hyperkalaemia, pleural effusion. Mylotarg dosage: 9 MG/M^2 1 PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with CYTARABINE, ACLARUBICIN HYDROCHLORIDE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4952650-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 17, 2004. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, chills, diarrhoea, dizziness
. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4995511-4
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Apr 21, 2006. Female patient, 72 years of age, weighting 121.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atrial flutter, blood alkaline phosphatase increased, blood urea increased, bradycardia, diarrhoea, febrile neutropenia, hypokalaemia. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS. During the same period patient was treated with NORVASC, ACTIVASE, ALLEGRA, DIFLUCAN, MORPHINE SULPHATE, PROTONIX, SERTRALINE. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4899281-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Jan 18, 2006. Female patient, 70 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, blood creatinine increased, blood urea increased, febrile neutropenia, fibrin degradation products increased, immunosuppression, interstitial lung disease, malignant neoplasm progression, pneumonia fungal. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with OZEX, ITRACONAZOLE, SULFAMETHOXAZOLE, URSO, ACTOS. Patient died.
Mylotarg Side Effects Report #4596656-3
Mylotarg side effect was reported by a Consumer or non-health professional from on Feb 22, 2005. Female patient, 69 years of age, weighting 143.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: abdominal distension, anaemia, anaphylactic reaction, biliary neoplasm, blood blister, blood creatine increased, blood urea increased, chills, dehydration. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4922071-6
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 14, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatine increased, blood urea increased, chills, dry mouth, dyspnoea, failure to thrive, fatigue, feeling abnormal, headache
. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.Mylotarg Side Effects Report #4942640-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Feb 28, 2006. Male patient, 69 years of age, weighting 276.2 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, atelectasis, blood bilirubin increased, blood creatinine increased, blood urea increased, chills, cholelithiasis, dry mouth. Mylotarg dosage: 21 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with DIPHENHYDRAMINE, ACETAMINOPHEN. Patient was hospitalized. Patient died on 05/06/2004.
Mylotarg Side Effects Report #4952637-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on June 23, 2004. Female patient, 69 years of age, weighting 143.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaphylactic reaction, blood urea increased, febrile neutropenia, gallbladder polyp, gastrointestinal haemorrhage, hepatic steatosis, hepatotoxicity, infection
, infusion related reaction. Mylotarg dosage: 15 MG 1X PER 1 DAY INTRAVENOUS. Patient was hospitalized. Patient recovered.Mylotarg Side Effects Report #4949624-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 08, 2006. Female patient, 66 years of age, weighting 151.1 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood urea increased, disease progression, febrile neutropenia, fluid overload, haemoglobin decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with CIPROFLOXACIN, DIFLUCAN, ACYCLOVIR, PROZAC, LOPRESSOR, PREVACID, COUMADIN. Patient was hospitalized. Patient died on 07/19/2003.
Mylotarg Side Effects Report #5073159-3
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on July 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, bilirubin conjugated increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #5106489-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Aug 30, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood bilirubin increased, blood lactate dehydrogenase increased, blood urea increased, decreased appetite, dizziness
, dyspnoea. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.Mylotarg Side Effects Report #5119380-7
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Sept 26, 2006. Male patient, 65 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, disease progression. Mylotarg dosage: 12 MG 1X PER 1 DAY, INTRAVENOUS. Patient died on 02/16/2006.
Mylotarg Side Effects Report #4553398-8
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 06, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood bilirubin increased, blood chloride increased, blood urea increased, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1X PER 1 DAY, INTRAVENOUS. Patient was hospitalized. Patient recovered.
Mylotarg Side Effects Report #4570073-4
Mylotarg side effect was reported by a Consumer or non-health professional from on Jan 17, 2005. Male patient, 65 years of age, weighting 166.7 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood bilirubin increased, blood chloride increased, blood urea increased, haemolysis, platelet count decreased, white blood cell count decreased. Mylotarg dosage: 18.6 MG 1 X PER 1 DAY, INTRAVENOUS. Patient recovered.
Mylotarg Side Effects Report #5191248-X
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Dec 04, 2006. Male patient, 57 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blast cells present, blood bilirubin increased, blood creatinine increased, blood urea increased, c-reactive protein increased, haematocrit decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP. During the same period patient was treated with PRODIF, FIRSTCIN, OMEPRAL, STRONG NEO MINOPHAGEN C. Patient recovered.
Mylotarg Side Effects Report #4706901-9
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 2004. Female patient, 50 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, acute respiratory distress syndrome, arthralgia, aspartate aminotransferase increased, asthenia, blood bilirubin increased, blood pressure increased, blood urea increased, haematocrit decreased. Mylotarg dosage: 4 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with MEDROXYPROGESTERONE ACETTE, ZOLPIDEM TARTRATE, ALLOPURINOL, ACYCLOVIR, CYCLOSPORINE, VITAMINS, ITRACONAZOLE. Patient was hospitalized. Patient died on 06/26/2000.
Mylotarg Side Effects Report #4949582-1
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Mar 07, 2006. Female patient, 50 years of age, weighting 129.0 lb, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: ascites, atelectasis, blood creatinine increased, blood urea increased, disease progression, disseminated intravascular coagulation, haemoglobin decreased, hypoalbuminaemia, hypotension. Mylotarg dosage: 15 MG 1X PER 1 DAY, INTRAVENOUS. During the same period patient was treated with BACTRIM DS, ADVAIR DISKUS, ALPHAGAN, ATROVENT, PROVENTIL, PROTONIX, AMBIEN, VITAMINS. Patient was hospitalized. Patient died on 10/02/2003.
Mylotarg Side Effects Report #5097592-9
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 23, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blood albumin decreased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood urea increased, fibrin degradation products increased, fungal sepsis, gamma-glutamyltransferase increased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B, DIFLUCAN, SULFAMETHOXAZOLE, MUCOSTA. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #5158265-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Nov 08, 2006. Male patient, 47 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: aspartate aminotransferase increased, blast cell count increased, blood alkaline phosphatase increased, blood bilirubin increased, blood creatinine increased, blood lactate dehydrogenase increased, blood urea increased, fibrin degradation products increased, fungal sepsis. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY, INTRAVENOUS DRIP. During the same period patient was treated with POLYMYXIN B SULPHATE, DIFLUCAN, SULFAMETHOXAZOLE, MUCOSTA, CYTARABINE, NOVANTRONE. Patient was hospitalized. Patient died.
Mylotarg Side Effects Report #4869962-2
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Dec 13, 2005. Male patient, 36 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood creatinine increased, blood urea increased, cardio-respiratory arrest, dyspnoea, epistaxis, febrile neutropenia, haematuria, hypotension, infection
. Mylotarg dosage: 6 MG/M^2 1X PER 1 DOS, INTRAVENOUS. During the same period patient was treated with CYTARABINE. Patient died on 11/22/2000.Mylotarg Side Effects Report #5097615-7
Mylotarg side effect was reported by a Consumer or non-health professional from JAPAN on Aug 22, 2006. Male patient, 30 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, anaemia, blood creatinine increased, blood potassium increased, blood urea increased, cystitis haemorrhagic, malignant neoplasm progression, mouth haemorrhage, platelet count decreased. Mylotarg dosage: 9 MG/M^2 1X PER 1 DAY INTRAVENOUS DRIP; SEE IMAGE. During the same period patient was treated with DIFLUCAN, AMLODIPINE BESYLATE, FAMOTIDINE, SULFAMETHOXAZOLE, PREDNISOLONE, LOSARTAN POTASSIUM, LASIX. Patient died.
Mylotarg Side Effects Report #4801401-X
Mylotarg side effect was reported by a Consumer or non-health professional from UNITED STATES on Nov 11, 1998. Female patient, 24 years of age, was diagnosed with acute myeloid leukaemia and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, ascites, aspartate aminotransferase increased, blood alkaline phosphatase increased, blood creatinine increased, blood urea increased, confusional state, dialysis
, dizziness . Mylotarg dosage: 9 MG /M (2), INTRAVENOUS. During the same period patient was treated with ABELCET. Patient was hospitalized. Patient died on 11/09/1998.Mylotarg Side Effects Report #5286578-7
Mylotarg side effect was reported by a Physician from JAPAN on Mar 27, 2007. Male patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, c-reactive protein increased, condition aggravated, performance status decreased, pneumonia
, white blood cell count increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, MEROPEN, AMIKACIN, GASTER, PREDONINE, DIFLUCAN, BAKTAR. Patient died on 02/16/2007.Mylotarg Side Effects Report #5289610-X
Mylotarg side effect was reported by a Physician from JAPAN on Mar 29, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, sepsis . Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ALTAT, SELBEX, GLUCOSEECTION, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/27/2007.Mylotarg Side Effects Report #5316413-X
Mylotarg side effect was reported by a Physician from JAPAN on Apr 26, 2007. Male patient, weighting 108.0 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: anaemia, blood urea increased, c-reactive protein increased, condition aggravated, performance status decreased, pneumonia
, white blood cell count increased. Mylotarg dosage: unknown. During the same period patient was treated with CYTARABINE, MEROPEN, AMIKACIN, GASTER, PREDONINE, DIFLUCAN, BAKTAR. Patient recovered.Mylotarg Side Effects Report #5379015-5
Mylotarg side effect was reported by a Physician from JAPAN on June 25, 2007. Female patient, weighting 77.16 lb, was diagnosed with acute myeloid leukaemia, pneumonia
, neutrophil count decreased and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: acute myeloid leukaemia, alanine aminotransferase increased, aspartate aminotransferase increased, blood urea increased, disease progression, liver disorder, neutrophil count decreased, pancytopenia, platelet count decreased. Mylotarg dosage: unknown. During the same period patient was treated with CIPROFLOXACIN, VANCOMYCIN, BIAPENEM, AMINOACETIC ACID. Patient was hospitalized. Patient died on 10/09/2006.Mylotarg Side Effects Report #5395435-7
Mylotarg side effect was reported by a Physician from JAPAN on July 17, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.Mylotarg Side Effects Report #5451515-9
Mylotarg side effect was reported by a Physician from JAPAN on Sept 04, 2007. Male patient, weighting 132.3 lb, was diagnosed with acute myeloid leukaemia, prophylaxis and was treated with Mylotarg. After drug was administered, patient experienced the following side effects: blood urea increased, cerebral haemorrhage, condition aggravated, disseminated intravascular coagulation, febrile neutropenia, hypernatraemia, pneumonia
, renal impairment. Mylotarg dosage: unknown. During the same period patient was treated with MAGNESIUM OXIDE, ROXATIDINE ACETATE, GLUCOSEECTION, DIFLUCAN, VITAMEDIN, SOLDEM, STRONG NEO MINOPHAGEN C. Patient was hospitalized. Patient died on 02/23/2007.